We are live on ! Find out more
RDUS

Radius Health, Inc.

Delisted

RDUS was delisted on the 12th of August, 2022.

135 hedge funds and large institutions have $602M invested in Radius Health, Inc. in 2021 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 47 increasing their positions, 43 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

145% more call options, than puts

Call options by funds: $3.77M | Put options by funds: $1.54M

31% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 16

3% more funds holding

Funds holding: 131135 (+4)

9% more repeat investments, than reductions

Existing positions increased: 47 | Existing positions reduced: 43

32% less capital invested

Capital invested by funds: $891M → $602M (-$289M)

Holders
135
Holders Change
+4
Holders Change %
+3.05%
% of All Funds
2.36%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
21
Increased
47
Reduced
43
Closed
16
Calls
$3.77M
Puts
$1.54M
Net Calls
+$2.23M
Net Calls Change
+$2.53M
Name Holding Trade Value Shares
Change
Change in
Stake
BG
1
Bellevue Group
Switzerland
$96.4M +$3.42M +237,300 +3%
T. Rowe Price Associates
2
T. Rowe Price Associates
Maryland
$95.5M -$4.01M -278,505 -3%
Vanguard Group
3
Vanguard Group
Pennsylvania
$58M +$183K +12,722 +0.3%
RCMNY
4
Rubric Capital Management (New York)
New York
$45.6M +$39.3M +2,727,837 +288%
BlackRock
5
BlackRock
New York
$43.7M -$1.95M -134,954 -4%
State Street
6
State Street
Massachusetts
$28.7M -$239K -16,581 -0.7%
Wellington Management Group
7
Wellington Management Group
Massachusetts
$27.4M -$16.1M -1,115,818 -34%
FCM
8
Farallon Capital Management
California
$26.2M
CCM
9
Camber Capital Management
Massachusetts
$18.6M
BNP Paribas Asset Management
10
BNP Paribas Asset Management
France
$13.1M -$2.72M -188,435 -15%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$10.1M -$469K -32,556 -4%
Jacobs Levy Equity Management
12
Jacobs Levy Equity Management
New Jersey
$9.14M -$1.24M -86,324 -10%
Goldman Sachs
13
Goldman Sachs
New York
$8.33M +$1.65M +114,585 +21%
Hudson Bay Capital Management
14
Hudson Bay Capital Management
Connecticut
$7.76M +$4.54M +315,000 +102%
Northern Trust
15
Northern Trust
Illinois
$6.49M -$107K -7,443 -1%
Morgan Stanley
16
Morgan Stanley
New York
$5.44M -$356K -24,712 -5%
RPAM
17
Rhenman & Partners Asset Management
Sweden
$5.34M
CS
18
Candriam SCA
Luxembourg
$5M
Charles Schwab
19
Charles Schwab
California
$4.66M +$32.2K +2,237 +0.6%
GIM
20
Granahan Investment Management
Massachusetts
$4.4M +$816K +56,628 +19%
Norges Bank
21
Norges Bank
Norway
$4.28M
JAM
22
Jupiter Asset Management
United Kingdom
$3.9M -$425K -29,463 -9%
N
23
Nuveen
North Carolina
$3.79M -$1.16M -80,661 -21%
PAMS
24
Pictet Asset Management (Switzerland)
Switzerland
$3.56M +$4.13M +286,722 New
Deutsche Bank
25
Deutsche Bank
Germany
$3.48M -$83.9K -5,817 -2%

RDUS Hedge Fund Activity: Q3 2021 in Review

135 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Radius Health, Inc. (RDUS) for Q3 2021, worth a combined $602M — down 32% from $891M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new RDUS positions and 16 closed out — a net gain of 5 holders — while 47 added to existing stakes and 43 trimmed.

The largest buyer was Rubric Capital Management (New York), adding an estimated $39.3M. The largest seller was Artisan Partners, exiting entirely with an estimated $29.4M sold.

  • 135 institutional investors held Radius Health, Inc. (RDUS) as of Q3 2021, up from 131 in Q2 2021.
  • Funds reported $602M of Radius Health, Inc. stock for Q3 2021, down 32% quarter-over-quarter.
  • 21 funds opened new Radius Health, Inc. positions in Q3 2021 and 16 closed out, a net change of +5 holders.
  • The largest Radius Health, Inc. buyer in Q3 2021 was Rubric Capital Management (New York), an estimated $39.3M added.
  • The largest Radius Health, Inc. seller in Q3 2021 was Artisan Partners, an estimated $29.4M sold.

Based on aggregated 13F filings for Q3 2021.